TreeWAS – Variant ID: rs218361

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N60.1 Diffuse cystic mastopathy	0.000	0.947	0.053
N60 Benign mammary dysplasia	0.000	0.950	0.050
N60.2 Fibroadenosis of breast	0.000	0.951	0.049
N60.8 Other benign mammary dysplasias	0.000	0.957	0.043
N60.0 Solitary cyst of breast	0.000	0.957	0.043
N60.4 Mammary duct ectasia	0.000	0.962	0.038
N60.9 Benign mammary dysplasia, unspecified	0.000	0.967	0.033
N60.3 Fibrosclerosis of breast	0.000	0.968	0.032
I83.1 Varicose veins of lower extremities with inflammation	0.000	0.989	0.011
G63.2 Diabetic polyneuropathy	0.000	0.990	0.010
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.007	0.993	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.007	0.993	0.000
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)	0.006	0.994	0.000
M07.3 Other psoriatic arthropathies	0.006	0.994	0.000
E10.4 With neurological complications	0.000	0.994	0.006
M07.34 Other psoriatic arthropathies (Hand)	0.005	0.995	0.000
M07.38 Other psoriatic arthropathies (Other)	0.005	0.995	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.005	0.995	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.005	0.995	0.000
J38.3 Other diseases of vocal cords	0.000	0.995	0.005
G63 Polyneuropathy in diseases classified elsewhere	0.000	0.995	0.005
M07.31 Other psoriatic arthropathies (Shoulder region)	0.005	0.995	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.004	0.995	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.004	0.995	0.000
Y43.3 Other antineoplastic drugs	0.005	0.995	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.004	0.995	0.000
C71.0 Cerebrum, except lobes and ventricles	0.000	0.996	0.004
D03.7 Melanoma in situ of lower limb, including hip	0.000	0.996	0.004
Z86.5 Personal history of other mental and behavioural disorders	0.004	0.996	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.000	0.996	0.004
E10.5 With peripheral circulatory complications	0.000	0.996	0.004
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.004	0.996	0.000
E10.3 With ophthalmic complications	0.000	0.996	0.004
G63.8 Polyneuropathy in other diseases classified elsewhere	0.000	0.996	0.004
G63.6 Polyneuropathy in other musculoskeletal disorders	0.000	0.996	0.004
G63.5 Polyneuropathy in systemic connective tissue disorders	0.000	0.996	0.004
G63.4 Polyneuropathy in nutritional deficiency	0.000	0.996	0.004
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.000	0.996	0.004
G63.1 Polyneuropathy in neoplastic disease	0.000	0.996	0.004
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.000	0.996	0.004
E10 Insulin-dependent diabetes mellitus	0.000	0.996	0.004
D03 Melanoma in situ	0.000	0.996	0.004
D03.4 Melanoma in situ of scalp and neck	0.000	0.996	0.004
E10.6 With other specified complications	0.000	0.996	0.004
C71.3 Parietal lobe	0.000	0.996	0.003
E10.7 With multiple complications	0.000	0.997	0.003
E10.2 With renal complications	0.000	0.997	0.003
Z04.3 Examination and observation following other accident	0.003	0.997	0.000
D61.9 Aplastic anaemia, unspecified	0.000	0.997	0.003
D03.6 Melanoma in situ of upper limb, including shoulder	0.000	0.997	0.003
D03.2 Melanoma in situ of ear and external auricular canal	0.000	0.997	0.003
D32.9 Meninges, unspecified	0.000	0.997	0.003
C71 Malignant neoplasm of brain	0.000	0.997	0.003
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.003	0.997	0.000
A40.8 Other streptococcal septicaemia	0.003	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
C71.4 Occipital lobe	0.000	0.997	0.003
D03.9 Melanoma in situ, unspecified	0.000	0.997	0.003
G30.9 Alzheimer's disease, unspecified	0.000	0.997	0.003
A40.3 Septicaemia due to Streptococcus pneumoniae	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
D48.7 Other specified sites	0.003	0.997	0.000
M81.40 Drug-induced osteoporosis (Multiple sites)	0.003	0.997	0.000
E10.0 With coma	0.000	0.997	0.003
E87.6 Hypokalaemia	0.000	0.997	0.003
C71.5 Cerebral ventricle	0.000	0.997	0.003
D03.0 Melanoma in situ of lip	0.000	0.997	0.003
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.003
D03.1 Melanoma in situ of eyelid, including canthus	0.000	0.997	0.003
G30.0 Alzheimer's disease with early onset	0.000	0.997	0.003
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
C71.8 Overlapping lesion of brain	0.000	0.997	0.003
C71.7 Brain stem	0.000	0.997	0.003
C71.9 Brain, unspecified	0.000	0.997	0.003
M07 Psoriatic and enteropathic arthropathies	0.003	0.997	0.000
D03.8 Melanoma in situ of other sites	0.000	0.997	0.002
A40 Streptococcal septicaemia	0.003	0.997	0.000
M25.06 Haemarthrosis (Lower leg)	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.997	0.000
I42.2 Other hypertrophic cardiomyopathy	0.000	0.997	0.003
X49.9 Unspecified place	0.002	0.997	0.000
R07.0 Pain in throat	0.002	0.998	0.000
S80.8 Other superficial injuries of lower leg	0.002	0.998	0.000
G30 Alzheimer's disease	0.000	0.998	0.002
C71.6 Cerebellum	0.000	0.998	0.002
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
E10.8 With unspecified complications	0.000	0.998	0.002
G12.2 Motor neuron disease	0.002	0.998	0.000
X68.9 Unspecified place	0.002	0.998	0.000
N60-N64 Disorders of breast	0.000	0.998	0.002
I11.9 Hypertensive heart disease without (congestive) heart failure	0.000	0.998	0.002
K25.0 Acute with haemorrhage	0.000	0.998	0.002
O36.0 Maternal care for rhesus isoimmunisation	0.002	0.998	0.000
R90.0 Intracranial space-occupying lesion	0.000	0.998	0.002
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.002	0.998	0.000
A40.0 Septicaemia due to streptococcus, group A	0.002	0.998	0.000
J38.0 Paralysis of vocal cords and larynx	0.000	0.998	0.002
J98.4 Other disorders of lung	0.000	0.998	0.002
N43.3 Hydrocele, unspecified	0.000	0.998	0.002
G30.1 Alzheimer's disease with late onset	0.000	0.998	0.002
D03.5 Melanoma in situ of trunk	0.000	0.998	0.002
N62 Hypertrophy of breast	0.000	0.998	0.002
M07.5 Arthropathy in ulcerative colitis	0.002	0.998	0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.002	0.998	0.000
M07.2 Psoriatic spondylitis	0.002	0.998	0.000
M07.1 Arthritis mutilans	0.002	0.998	0.000
M07.0 Distal interphalangeal psoriatic arthropathy	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
A40.1 Septicaemia due to streptococcus, group B	0.002	0.998	0.000
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.998	0.002
A40.2 Septicaemia due to streptococcus, group D	0.002	0.998	0.000
M07.6 Other enteropathic arthropathies	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.002
Y42.4 Oral contraceptives	0.002	0.998	0.000
F40.2 Specific (isolated) phobias	0.002	0.998	0.000
R73.0 Abnormal glucose tolerance test	0.000	0.998	0.002
A40.9 Streptococcal septicaemia, unspecified	0.002	0.998	0.000
K60.0 Acute anal fissure	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
Z83.3 Family history of diabetes mellitus	0.000	0.998	0.002
G30.8 Other Alzheimer's disease	0.000	0.998	0.002
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
B25.9 Cytomegaloviral disease, unspecified	0.000	0.998	0.002
F20.0 Paranoid schizophrenia	0.002	0.998	0.000
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.998	0.002
M35.3 Polymyalgia rheumatica	0.002	0.998	0.000
M35.0 Sicca syndrome [Sjogren]	0.002	0.998	0.000
G62.8 Other specified polyneuropathies	0.000	0.998	0.002
D48.6 Breast	0.002	0.998	0.000
L50.0 Allergic urticaria	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
C71.2 Temporal lobe	0.000	0.998	0.002
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)	0.002	0.998	0.000
M07.08 Distal interphalangeal proriatic arthropathy-Other	0.002	0.998	0.000
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)	0.002	0.998	0.000
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg	0.002	0.998	0.000
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh	0.002	0.998	0.000
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)	0.002	0.998	0.000
M07.03 Distal interphalangeal proriatic arthropathy-Forearm	0.002	0.998	0.000
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm	0.002	0.998	0.000
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region	0.002	0.998	0.000
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)	0.002	0.998	0.000
M07.19 Arthritis mutilans (Site unspecified)	0.002	0.998	0.000
M07.18 Arthritis mutilans (Other)	0.002	0.998	0.000
M07.17 Arthritis mutilans (Ankle and foot)	0.002	0.998	0.000
M07.16 Arthritis mutilans (Lower leg)	0.002	0.998	0.000
M07.15 Arthritis mutilans (Pelvic region and thigh)	0.002	0.998	0.000
M07.14 Arthritis mutilans (Hand)	0.002	0.998	0.000
M07.13 Arthritis mutilans (Forearm)	0.002	0.998	0.000
M07.12 Arthritis mutilans (Upper arm)	0.002	0.998	0.000
M07.11 Arthritis mutilans (Shoulder region)	0.002	0.998	0.000
M07.10 Arthritis mutilans (Multiple sites)	0.002	0.998	0.000
M07.29 Psoriatic spondylitis (Site unspecified)	0.002	0.998	0.000
M07.28 Psoriatic spondylitis (Other)	0.002	0.998	0.000
M07.27 Psoriatic spondylitis (Ankle and foot)	0.002	0.998	0.000
M07.26 Psoriatic spondylitis (Lower leg)	0.002	0.998	0.000
M07.25 Psoriatic spondylitis (Pelvic region and thigh)	0.002	0.998	0.000
M07.24 Psoriatic spondylitis (Hand)	0.002	0.998	0.000
M07.23 Psoriatic spondylitis (Forearm)	0.002	0.998	0.000
M07.22 Psoriatic spondylitis (Upper arm)	0.002	0.998	0.000
M07.21 Psoriatic spondylitis (Shoulder region)	0.002	0.998	0.000
M07.20 Psoriatic spondylitis (Multiple sites)	0.002	0.998	0.000
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)	0.002	0.998	0.000
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)	0.002	0.998	0.000
M07.47 Arthropathy in Crohn's disease [regional enteritis] (Ankle and foot)	0.002	0.998	0.000
M07.46 Arthropathy in Crohn's disease [regional enteritis] (Lower leg)	0.002	0.998	0.000
M07.45 Arthropathy in Crohn's disease [regional enteritis] (Pelvic region and thigh)	0.002	0.998	0.000
M07.44 Arthropathy in Crohn's disease [regional enteritis] (Hand)	0.002	0.998	0.000
M07.43 Arthropathy in Crohn's disease [regional enteritis] (Forearm)	0.002	0.998	0.000
M07.42 Arthropathy in Crohn's disease [regional enteritis] (Upper arm)	0.002	0.998	0.000
M07.41 Arthropathy in Crohn's disease [regional enteritis] (Shoulder region)	0.002	0.998	0.000
M07.40 Arthropathy in Crohn's disease [regional enteritis] (Multiple sites)	0.002	0.998	0.000
M07.59 Arthropathy in ulcerative colitis (Site unspecified)	0.002	0.998	0.000
M07.58 Arthropathy in ulcerative colitis (Other)	0.002	0.998	0.000
M07.57 Arthropathy in ulcerative colitis (Ankle and foot)	0.002	0.998	0.000
M07.56 Arthropathy in ulcerative colitis (Lower leg)	0.002	0.998	0.000
M07.55 Arthropathy in ulcerative colitis (Pelvic region and thigh)	0.002	0.998	0.000
M07.54 Arthropathy in ulcerative colitis (Hand)	0.002	0.998	0.000
M07.53 Arthropathy in ulcerative colitis (Forearm)	0.002	0.998	0.000
M07.52 Arthropathy in ulcerative colitis (Upper arm)	0.002	0.998	0.000
M07.51 Arthropathy in ulcerative colitis (Shoulder region)	0.002	0.998	0.000
M07.50 Arthropathy in ulcerative colitis (Multiple sites)	0.002	0.998	0.000
C71.1 Frontal lobe	0.000	0.998	0.002
M07.68 Other enteropathic arthropathies (Other)	0.002	0.998	0.000
M07.67 Other enteropathic arthropathies (Ankle and foot)	0.002	0.998	0.000
M07.66 Other enteropathic arthropathies (Lower leg)	0.002	0.998	0.000
M07.65 Other enteropathic arthropathies (Pelvic region and thigh)	0.002	0.998	0.000
M07.64 Other enteropathic arthropathies (Hand)	0.002	0.998	0.000
M07.63 Other enteropathic arthropathies (Forearm)	0.002	0.998	0.000
M07.62 Other enteropathic arthropathies (Upper arm)	0.002	0.998	0.000
M07.61 Other enteropathic arthropathies (Shoulder region)	0.002	0.998	0.000
M07.60 Other enteropathic arthropathies (Multiple sites)	0.002	0.998	0.000
R73.9 Hyperglycaemia, unspecified	0.000	0.998	0.002
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.000	0.998	0.002
Y43 Primarily systemic agents	0.002	0.998	0.000
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.000	0.998	0.002
J13 Pneumonia due to Streptococcus pneumoniae	0.002	0.998	0.000
M07.69 Other enteropathic arthropathies (Site unspecified)	0.002	0.998	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.002	0.998	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.002	0.998	0.000
F10.3 Withdrawal state	0.002	0.998	0.000
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.000	0.998	0.002
L51.9 Erythema multiforme, unspecified	0.002	0.998	0.000
D32 Benign neoplasm of meninges	0.000	0.998	0.002
D32.1 Spinal meninges	0.000	0.998	0.002
K25.3 Acute without haemorrhage or perforation	0.000	0.998	0.002
E10.1 With ketoacidosis	0.001	0.998	0.000
J38.7 Other diseases of larynx	0.000	0.998	0.002
N99.8 Other postprocedural disorders of genito-urinary system	0.002	0.998	0.000
L27.1 Localised skin eruption due to drugs and medicaments	0.002	0.998	0.000
T84.6 Infection and inflammatory reaction due to internal fixation device [any site]	0.002	0.998	0.000
R73 Elevated blood glucose level	0.000	0.998	0.002
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.998	0.002
M81.4 Drug-induced osteoporosis	0.002	0.998	0.000
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
M89.04 Algoneurodystrophy (Hand)	0.002	0.998	0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.000	0.998	0.002
G62.1 Alcoholic polyneuropathy	0.000	0.998	0.002
Y43.9 Primarily systemic agent, unspecified	0.001	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.001	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.001	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.001	0.998	0.000
G62 Other polyneuropathies	0.000	0.998	0.002
R90 Abnormal findings on diagnostic imaging of central nervous system	0.000	0.998	0.002
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.002	0.998	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.002	0.998	0.000
X68.8 Other specified place	0.001	0.998	0.000
X68.7 Farm	0.001	0.998	0.000
X68.6 Industrial and construction area	0.001	0.998	0.000
X68.5 Trade and service area	0.001	0.998	0.000
X68.4 Street and highway	0.001	0.998	0.000
X68.3 Sports and athletics area	0.001	0.998	0.000
X68.2 School, other institution and public administrative area	0.001	0.998	0.000
X68.1 Residential institution	0.001	0.998	0.000
X68.0 Home	0.001	0.998	0.000
E04.1 Non-toxic single thyroid nodule	0.000	0.998	0.002
I69 Sequelae of cerebrovascular disease	0.002	0.998	0.000
G45.3 Amaurosis fugax	0.002	0.998	0.000
G12 Spinal muscular atrophy and related syndromes	0.001	0.998	0.000
F40.8 Other phobic anxiety disorders	0.001	0.998	0.000
G62.0 Drug-induced polyneuropathy	0.000	0.998	0.001
K26.3 Acute without haemorrhage or perforation	0.000	0.998	0.002
W55.0 Home	0.000	0.998	0.001
H47.3 Other disorders of optic disk	0.000	0.999	0.001
Y45.2 Propionic acid derivatives	0.000	0.999	0.001
M35 Other systemic involvement of connective tissue	0.001	0.999	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.001	0.999	0.000
F50.0 Anorexia nervosa	0.001	0.999	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.001	0.999	0.000
M35.4 Diffuse (eosinophilic) fasciitis	0.001	0.999	0.000
O47.9 False labour, unspecified	0.000	0.999	0.001
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.999	0.001
Y43.2 Antineoplastic natural products	0.001	0.999	0.000
F40 Phobic anxiety disorders	0.001	0.999	0.000
G64 Other disorders of peripheral nervous system	0.000	0.999	0.001
F40.0 Agoraphobia	0.001	0.999	0.000
L50.1 Idiopathic urticaria	0.001	0.999	0.000
M35.8 Other specified systemic involvement of connective tissue	0.001	0.999	0.000
M81.48 Drug-induced osteoporosis (Other)	0.001	0.999	0.000
M81.47 Drug-induced osteoporosis (Ankle and foot)	0.001	0.999	0.000
M81.46 Drug-induced osteoporosis (Lower leg)	0.001	0.999	0.000
M81.45 Drug-induced osteoporosis (Pelvic region and thigh)	0.001	0.999	0.000
M81.44 Drug-induced osteoporosis (Hand)	0.001	0.999	0.000
M81.43 Drug-induced osteoporosis (Forearm)	0.001	0.999	0.000
M81.42 Drug-induced osteoporosis (Upper arm)	0.001	0.999	0.000
M81.41 Drug-induced osteoporosis (Shoulder region)	0.001	0.999	0.000
S72.20 Subtrochanteric fracture (closed)	0.000	0.999	0.001
J38.2 Nodules of vocal cords	0.000	0.999	0.001
M80.0 Postmenopausal osteoporosis with pathological fracture	0.001	0.999	0.000
X49.4 Street and highway	0.001	0.999	0.000
X49.0 Home	0.001	0.999	0.000
X49.8 Other specified place	0.001	0.999	0.000
X49.7 Farm	0.001	0.999	0.000
X49.6 Industrial and construction area	0.001	0.999	0.000
X49.5 Trade and service area	0.001	0.999	0.000
X49.3 Sports and athletics area	0.001	0.999	0.000
X49.2 School, other institution and public administrative area	0.001	0.999	0.000
X49.1 Residential institution	0.001	0.999	0.000
E85.9 Amyloidosis, unspecified	0.001	0.999	0.000
M35.1 Other overlap syndromes	0.001	0.999	0.000
X60.1 Residential institution	0.001	0.999	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.000	0.999	0.001
M62.81 Other specified disorders of muscle (Shoulder region)	0.000	0.999	0.001
G62.2 Polyneuropathy due to other toxic agents	0.000	0.999	0.001
X64.8 Other specified place	0.001	0.999	0.000
M89.03 Algoneurodystrophy (Forearm)	0.001	0.999	0.000
E85.4 Organ-limited amyloidosis	0.001	0.999	0.000
S72.40 Fracture of lower end of femur (closed)	0.001	0.999	0.000
G12.9 Spinal muscular atrophy, unspecified	0.001	0.999	0.000
G12.8 Other spinal muscular atrophies and related syndromes	0.001	0.999	0.000
G12.1 Other inherited spinal muscular atrophy	0.001	0.999	0.000
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]	0.001	0.999	0.000
K85.9 Acute pancreatitis, unspecified	0.000	0.999	0.001
O41.0 Oligohydramnios	0.001	0.999	0.000
R44.3 Hallucinations, unspecified	0.000	0.999	0.001
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.001	0.999	0.000
M81.49 Drug-induced osteoporosis (Site unspecified)	0.001	0.999	0.000
M35.9 Systemic involvement of connective tissue, unspecified	0.001	0.999	0.000
M35.6 Relapsing panniculitis [Weber-Christian]	0.001	0.999	0.000
M35.5 Multifocal fibrosclerosis	0.001	0.999	0.000
V80.9 Rider or occupant injured in other and unspecified transport accidents	0.000	0.999	0.001
K25 Gastric ulcer	0.000	0.999	0.001
F20.2 Catatonic schizophrenia	0.001	0.999	0.000
F40.1 Social phobias	0.001	0.999	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.001	0.999	0.000
J38.6 Stenosis of larynx	0.000	0.999	0.001
J38.1 Polyp of vocal cord and larynx	0.000	0.999	0.001
X69.0 Home	0.001	0.999	0.000
C70 Malignant neoplasm of meninges	0.000	0.999	0.001
M80.09 Postmenopausal osteoporosis with pathological fracture (Site unspecified)	0.001	0.999	0.000
M80.08 Postmenopausal osteoporosis with pathological fracture (Other)	0.001	0.999	0.000
M80.07 Postmenopausal osteoporosis with pathological fracture (Ankle and foot)	0.001	0.999	0.000
M80.06 Postmenopausal osteoporosis with pathological fracture (Lower leg)	0.001	0.999	0.000
M80.05 Postmenopausal osteoporosis with pathological fracture (Pelvic region and thigh)	0.001	0.999	0.000
M80.04 Postmenopausal osteoporosis with pathological fracture (Hand)	0.001	0.999	0.000
M80.03 Postmenopausal osteoporosis with pathological fracture (Forearm)	0.001	0.999	0.000
M80.02 Postmenopausal osteoporosis with pathological fracture (Upper arm)	0.001	0.999	0.000
M80.01 Postmenopausal osteoporosis with pathological fracture (Shoulder region)	0.001	0.999	0.000
D32.0 Cerebral meninges	0.000	0.999	0.001
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.001	0.999	0.000
L28.0 Lichen simplex chronicus	0.001	0.999	0.000
X61.4 Street and highway	0.001	0.999	0.000
Y00.9 Unspecified place	0.001	0.999	0.000
D61 Other aplastic anaemias	0.000	0.999	0.001
L50 Urticaria	0.001	0.999	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.001	0.999	0.000
X49.09 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances; Home; During unspecified activity	0.001	0.999	0.000
X49.48 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances; Street and highway;While engaged in other specified activities	0.001	0.999	0.000
D48.4 Peritoneum	0.001	0.999	0.000
F40.9 Phobic anxiety disorder, unspecified	0.001	0.999	0.000
H47.1 Papilloedema, unspecified	0.000	0.999	0.001
H47.0 Disorders of optic nerve, not elsewhere classified	0.000	0.999	0.001
I69.3 Sequelae of cerebral infarction	0.001	0.999	0.000
K72.0 Acute and subacute hepatic failure	0.000	0.999	0.001
S79.9 Unspecified injury of hip and thigh	0.000	0.999	0.001
X64.2 School, other institution and public administrative area	0.001	0.999	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.001	0.999	0.000
H92.1 Otorrhoea	0.001	0.999	0.000
K26.6 Chronic or unspecified with both haemorrhage and perforation	0.000	0.999	0.001
K82.4 Cholesterolosis of gallbladder	0.000	0.999	0.001
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
C69.6 Orbit	0.000	0.999	0.001
C70.0 Cerebral meninges	0.000	0.999	0.001
D61.0 Constitutional aplastic anaemia	0.000	0.999	0.001
T56.8 Other metals	0.001	0.999	0.000
X80.0 Home	0.001	0.999	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.001	0.999	0.000
M79.19 Myalgia (Site unspecified)	0.000	0.999	0.001
M89.09 Algoneurodystrophy (Site unspecified)	0.001	0.999	0.000
A41.1 Septicaemia due to other specified staphylococcus	0.000	0.999	0.001
J04.0 Acute laryngitis	0.000	0.999	0.001
V44.5 Driver injured in traffic accident	0.001	0.999	0.000
X64.9 Unspecified place	0.001	0.999	0.000
X64.0 Home	0.001	0.999	0.000
X64.7 Farm	0.001	0.999	0.000
X64.6 Industrial and construction area	0.001	0.999	0.000
X64.5 Trade and service area	0.001	0.999	0.000
X64.4 Street and highway	0.001	0.999	0.000
X64.3 Sports and athletics area	0.001	0.999	0.000
X64.1 Residential institution	0.001	0.999	0.000
C20 Malignant neoplasm of rectum	0.001	0.999	0.000
X80 Intentional self-harm by jumping from a high place	0.001	0.999	0.000
X60-X84 Intentional self-harm	0.001	0.999	0.000
M19.93 Arthrosis, unspecified (Forearm)	0.000	0.999	0.001
M35.99 Systemic involvement of connective tissue, unspecified, Site unspecified	0.001	0.999	0.000
C69.3 Choroid	0.000	0.999	0.001
C70.9 Meninges, unspecified	0.000	0.999	0.001
C70.1 Spinal meninges	0.000	0.999	0.001
I68.0 Cerebral amyloid angiopathy	0.001	0.999	0.000
K25.2 Acute with both haemorrhage and perforation	0.000	0.999	0.001
K25.1 Acute with perforation	0.000	0.999	0.001
M35.2 Behcet's disease	0.001	0.999	0.000
X60.8 Other specified place	0.001	0.999	0.000
C69 Malignant neoplasm of eye and adnexa	0.000	0.999	0.001
C00.0 External upper lip	0.000	0.999	0.001
D61.8 Other specified aplastic anaemias	0.000	0.999	0.001
D61.3 Idiopathic aplastic anaemia	0.000	0.999	0.001
D61.2 Aplastic anaemia due to other external agents	0.000	0.999	0.001
L28.2 Other prurigo	0.001	0.999	0.000
L50.6 Contact urticaria	0.001	0.999	0.000
L50.5 Cholinergic urticaria	0.001	0.999	0.000
L50.4 Vibratory urticaria	0.001	0.999	0.000
L50.3 Dermatographic urticaria	0.001	0.999	0.000
L50.2 Urticaria due to cold and heat	0.001	0.999	0.000
R77.0 Abnormality of albumin	0.000	0.999	0.001
X60.9 Unspecified place	0.001	0.999	0.000
X60.0 Home	0.001	0.999	0.000
X60.7 Farm	0.001	0.999	0.000
X60.6 Industrial and construction area	0.001	0.999	0.000
X60.4 Street and highway	0.001	0.999	0.000
X60.3 Sports and athletics area	0.001	0.999	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.000	0.999	0.001
H47 Other disorders of optic [2nd] nerve and visual pathways	0.000	0.999	0.001
L51 Erythema multiforme	0.001	0.999	0.000
E89.2 Postprocedural hypoparathyroidism	0.001	0.999	0.000
J01.9 Acute sinusitis, unspecified	0.000	0.999	0.001
O34.1 Maternal care for tumour of corpus uteri	0.000	0.999	0.001
X60.5 Trade and service area	0.001	0.999	0.000
X61.9 Unspecified place	0.001	0.999	0.000
X61.8 Other specified place	0.001	0.999	0.000
X61.0 Home	0.001	0.999	0.000
X61.7 Farm	0.001	0.999	0.000
X61.6 Industrial and construction area	0.001	0.999	0.000
X61.5 Trade and service area	0.001	0.999	0.000
X61.3 Sports and athletics area	0.001	0.999	0.000
X61.2 School, other institution and public administrative area	0.001	0.999	0.000
X61.1 Residential institution	0.001	0.999	0.000
Z09.2 Follow-up examination after chemotherapy for other conditions	0.001	0.999	0.000
F20 Schizophrenia	0.001	0.999	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.001	0.999	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.001	0.999	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.001	0.999	0.000
K91.4 Colostomy and enterostomy malfunction	0.001	0.999	0.000
M89.0 Algoneurodystrophy	0.001	0.999	0.000
O12.1 Gestational proteinuria	0.001	0.999	0.000
X67.9 Unspecified place	0.001	0.999	0.000
X69.8 Other specified place	0.001	0.999	0.000
X69.7 Farm	0.001	0.999	0.000
X69.6 Industrial and construction area	0.001	0.999	0.000
X69.5 Trade and service area	0.001	0.999	0.000
X69.4 Street and highway	0.001	0.999	0.000
X69.3 Sports and athletics area	0.001	0.999	0.000
X69.2 School, other institution and public administrative area	0.001	0.999	0.000
X69.1 Residential institution	0.001	0.999	0.000
Y43.1 Antineoplastic antimetabolites	0.001	0.999	0.000
I42 Cardiomyopathy	0.000	0.999	0.001
L52 Erythema nodosum	0.001	0.999	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.001	0.999	0.000
X64.09 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances; Home; During unspecified activity	0.001	0.999	0.000
X64.99 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances, Unspecified place, During unspecified activity	0.001	0.999	0.000
D48.3 Retroperitoneum	0.001	0.999	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.001	0.999	0.000
K43.0 Ventral hernia with obstruction, without gangrene	0.000	0.999	0.001
X80.9 Unspecified place	0.001	0.999	0.000
X80.8 Other specified place	0.001	0.999	0.000
X80.7 Farm	0.001	0.999	0.000
X80.6 Industrial and construction area	0.001	0.999	0.000
X80.5 Trade and service area	0.001	0.999	0.000
X80.4 Street and highway	0.001	0.999	0.000
X80.3 Sports and athletics area	0.001	0.999	0.000
X80.2 School, other institution and public administrative area	0.001	0.999	0.000
X80.1 Residential institution	0.001	0.999	0.000
Z34.9 Supervision of normal pregnancy, unspecified	0.000	0.999	0.001
B25 Cytomegaloviral disease	0.000	0.999	0.001
I11 Hypertensive heart disease	0.000	0.999	0.001
X84 Intentional self-harm by unspecified means	0.001	0.999	0.000
X83 Intentional self-harm by other specified means	0.001	0.999	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.001	0.999	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.001	0.999	0.000
X79 Intentional self-harm by blunt object	0.001	0.999	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.001	0.999	0.000
X76 Intentional self-harm by smoke, fire and flames	0.001	0.999	0.000
X75 Intentional self-harm by explosive material	0.001	0.999	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.001	0.999	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.001	0.999	0.000
X72 Intentional self-harm by handgun discharge	0.001	0.999	0.000
X71 Intentional self-harm by drowning and submersion	0.001	0.999	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.001	0.999	0.000
X60.09 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics; Home; During unspecified activity	0.001	0.999	0.000
X60.08 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, Home , While engaged in other specified activities	0.001	0.999	0.000
X60.99 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, Unspecified place, During unspecified activity	0.001	0.999	0.000
B25.0 Cytomegaloviral pneumonitis	0.000	0.999	0.001
C69.8 Overlapping lesion of eye and adnexa	0.000	0.999	0.001
C69.5 Lachrymal gland and duct	0.000	0.999	0.001
C69.1 Cornea	0.000	0.999	0.001
H47.7 Disorder of visual pathways, unspecified	0.000	0.999	0.001
H47.6 Disorders of visual cortex	0.000	0.999	0.001
H47.4 Disorders of optic chiasm	0.000	0.999	0.001
L51.8 Other erythema multiforme	0.001	0.999	0.000
L51.2 Toxic epidermal necrolysis [Lyell]	0.001	0.999	0.000
L51.0 Nonbullous erythema multiforme	0.001	0.999	0.000
Q76.0 Spina bifida occulta	0.000	0.999	0.001
X42.2 School, other institution and public administrative area	0.001	0.999	0.000
X65.8 Other specified place	0.001	0.999	0.000
X70.2 School, other institution and public administrative area	0.001	0.999	0.000
M80.50 Idiopathic osteoporosis with pathological fracture (Multiple sites)	0.001	0.999	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.001	0.999	0.000
X61.09 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified, Home , During unspecified activity	0.001	0.999	0.000
X61.08 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified; Home; While engaged in other specified activit	0.001	0.999	0.000
X61.88 Intentional self-poisoning by and exposure to antiepileptic,sedative-hypnotic,antiparkinsonism and psychotropic drugs,not elsewhere classified.Place/activity:other specified	0.001	0.999	0.000
X61.99 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified, Unspecified place, During unspecified activity	0.001	0.999	0.000
X61.98 Intentional self-poisoning by and exposure to antiepileptic,sedative-hypnotic,antiparkinsonism and psychotropic drugs,not elsewhere classified.Unspecified place.Other specified activities.	0.001	0.999	0.000
C72.9 Central nervous system, unspecified	0.000	0.999	0.001
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.000	0.999	0.001
C72.5 Other and unspecified cranial nerves	0.000	0.999	0.001
C72.4 Acoustic nerve	0.000	0.999	0.001
C72.3 Optic nerve	0.000	0.999	0.001
C72.2 Olfactory nerve	0.000	0.999	0.001
C72.1 Cauda equina	0.000	0.999	0.001
D48.2 Peripheral nerves and autonomic nervous system	0.001	0.999	0.000
F20.6 Simple schizophrenia	0.001	0.999	0.000
F20.4 Postschizophrenic depression	0.001	0.999	0.000
F20.3 Undifferentiated schizophrenia	0.001	0.999	0.000
F20.1 Hebephrenic schizophrenia	0.001	0.999	0.000
K25.5 Chronic or unspecified with perforation	0.000	0.999	0.001
M25.0 Haemarthrosis	0.001	0.999	0.000
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.001	0.999	0.000
X41.9 Unspecified place	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations